InsiderClue
Stocks · Health care · Pharmaceutical Preparations

China SXT Pharmaceuticals, Inc.

SXTC Clue Score29
Virgin Islands, British Fiscal year ends March CIK 0001723980
$0.10 -31.41% Close, 12 Oct 2026
Alert on the numbers Alert on insider trades
Price $0.10 −89.48% Close, 12 Oct 2026

Closing prices at the end of each trading day, from 4 Jan 2019. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2017Revenue4.9Operating income1.6Net income1.2EPS, diluted0.06Fiscal year 2018Revenue7.0 +43.8%Operating income1.6Net income1.2 +0.2%EPS, diluted0.06Fiscal year 2019Revenue7.0 −0.1%Operating income1.8Net income1.5 +29.6%EPS, diluted0.08Fiscal year 2020Revenue5.2 −26.4%Operating income−1.3Net income−10.3 −768.4%Fiscal year 2021Revenue4.8 −7.5%Operating income−2.2Net income−2.7EPS, diluted−3.82Fiscal year 2022Revenue2.6 −45.5%Operating income−5.2Net income−5.7EPS, diluted−137.92Fiscal year 2023Revenue2.0 −24.2%Operating income−5.6Net income−5.9EPS, diluted−177.84Fiscal year 2024Revenue1.9 −2.2%Operating income−2.5Net income−3.1EPS, diluted−4,285.66Fiscal year 2025Revenue1.7 −9.7%Operating income−2.7Net income−3.3EPS, diluted−348.17Fiscal year 2026Revenue1.1 −34.6%Operating income−7.1Net income−6.2EPS, diluted−9.13
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Revenue 4.9 7.0 7.0 5.2 4.8 2.6 2.0 1.9 1.7 1.1
Growth +43.8% −0.1% −26.4% −7.5% −45.5% −24.2% −2.2% −9.7% −34.6%
Operating income 1.6 1.6 1.8 −1.3 −2.2 −5.2 −5.6 −2.5 −2.7 −7.1
Net income 1.2 1.2 1.5 −10.3 −2.7 −5.7 −5.9 −3.1 −3.3 −6.2
Growth +0.2% +29.6% −768.4%
EPS, diluted 0.06 0.06 0.08 n/a −3.82 −137.92 −177.84 −4,285.66 −348.17 −9.13

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2017Gross margin47.4%Operating margin32.8%Net margin24.3%Free cash flow margin2.3%Fiscal year 2018Gross margin48.5%Operating margin23.3%Net margin16.9%Free cash flow margin21.1%Fiscal year 2019Gross margin65.8%Operating margin25.2%Net margin22.0%Free cash flow margin−4.2%Fiscal year 2020Gross margin52.4%Operating margin−26.0%Net margin−199.3%Free cash flow margin15.6%Fiscal year 2021Gross margin59.4%Operating margin−46.0%Net margin−57.5%Fiscal year 2022Gross margin48.1%Operating margin−199.4%Net margin−220.4%Fiscal year 2023Gross margin21.6%Operating margin−284.4%Net margin−301.0%Fiscal year 2024Gross margin28.7%Operating margin−130.4%Net margin−160.7%Free cash flow margin−100.3%Fiscal year 2025Gross margin21.1%Operating margin−154.0%Net margin−189.8%Free cash flow margin−134.8%Fiscal year 2026Gross margin21.9%Operating margin−625.9%Net margin−545.2%
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Gross margin 47.4% 48.5% 65.8% 52.4% 59.4% 48.1% 21.6% 28.7% 21.1% 21.9%
Operating margin 32.8% 23.3% 25.2% −26.0% −46.0% −199.4% −284.4% −130.4% −154.0% −625.9%
Net margin 24.3% 16.9% 22.0% −199.3% −57.5% −220.4% −301.0% −160.7% −189.8% −545.2%
Free cash flow margin 2.3% 21.1% −4.2% 15.6% n/a n/a n/a −100.3% −134.8% n/a

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2017Operating cash flow0.3Capital expenditure−0.2Free cash flow0.1Fiscal year 2018Operating cash flow1.9Capital expenditure−0.4Free cash flow1.5 +1,203.4%Fiscal year 2019Operating cash flow0.2Capital expenditure−0.5Free cash flow−0.3 −120.0%Fiscal year 2020Operating cash flow0.9Capital expenditure−0.1Free cash flow0.8Fiscal year 2021Operating cash flow−1.3Fiscal year 2022Operating cash flow0.3Fiscal year 2023Operating cash flow−0.1Fiscal year 2024Operating cash flow−1.9Capital expenditure−0.0Free cash flow−1.9Fiscal year 2025Operating cash flow−2.3Capital expenditure−0.0Free cash flow−2.3Fiscal year 2026Operating cash flow−4.0
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Operating cash flow 0.3 1.9 0.2 0.9 −1.3 0.3 −0.1 −1.9 −2.3 −4.0
Capital expenditure −0.2 −0.4 −0.5 −0.1 n/a n/a n/a −0.0 −0.0 n/a
Free cash flow 0.1 1.5 −0.3 0.8 n/a n/a n/a −1.9 −2.3 n/a
Growth +1,203.4% −120.0%

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2017Cash0.1Shareholders’ equity1.9Fiscal year 2018Cash0.7Shareholders’ equity3.3Fiscal year 2019Cash9.3Total debt0.0Net cash (debt)9.3Shareholders’ equity11.1Debt to equity0.00Fiscal year 2020Cash7.3Total debt0.0Net cash (debt)7.3Shareholders’ equity9.4Debt to equity0.00Fiscal year 2021Cash13.4Total debt0.0Net cash (debt)13.4Shareholders’ equity16.0Debt to equity0.00Fiscal year 2022Cash15.5Total debt0.0Net cash (debt)15.5Shareholders’ equity16.1Debt to equity0.00Fiscal year 2023Cash17.4Total debt0.1Net cash (debt)17.2Shareholders’ equity14.7Debt to equity0.01Fiscal year 2024Cash12.1Total debt0.1Net cash (debt)11.9Shareholders’ equity13.9Debt to equity0.01Fiscal year 2025Cash18.1Total debt0.1Net cash (debt)18.0Shareholders’ equity15.4Debt to equity0.01Fiscal year 2026Cash28.2Total debt0.6Net cash (debt)27.5Shareholders’ equity29.7Debt to equity0.02
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Cash 0.1 0.7 9.3 7.3 13.4 15.5 17.4 12.1 18.1 28.2
Total debt n/a n/a 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.6
Net cash (debt) n/a n/a 9.3 7.3 13.4 15.5 17.2 11.9 18.0 27.5
Shareholders’ equity 1.9 3.3 11.1 9.4 16.0 16.1 14.7 13.9 15.4 29.7
Debt to equity n/a n/a 0.00 0.00 0.00 0.00 0.01 0.01 0.01 0.02

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2026 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending March, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2017 31 Mar 2017 FY2018 31 Mar 2018 FY2019 31 Mar 2019 FY2020 31 Mar 2020 FY2021† 31 Mar 2021 FY2022† 31 Mar 2022 FY2023 31 Mar 2023 FY2024† 31 Mar 2024 FY2025† 31 Mar 2025 FY2026† 31 Mar 2026
Revenue and profit
4.9 7.0 7.0 5.2 4.8 2.6 2.0 1.9 1.7 1.1
Growth +43.8% −0.1% −26.4% −7.5% −45.5% −24.2% −2.2% −9.7% −34.6%
2.6 3.6 2.4 2.5 1.9 1.4 1.5 1.4 1.4 0.9
2.3 3.4 4.6 2.7 2.8 1.3 0.4 0.6 0.4 0.2
Growth +47.1% +35.6% −41.4% +5.0% −55.9% −65.9% +30.0% −33.7% −32.3%
n/a n/a n/a n/a n/a 0.4 0.2 0.2 n/a n/a
0.6 1.3 1.2 2.5 3.4 5.5 5.6 2.6 2.8 7.1
1.6 1.6 1.8 −1.3 −2.2 −5.2 −5.6 −2.5 −2.7 −7.1
Growth +1.9% +8.4% −175.8%
1.6 1.6 1.8 −10.4 −2.9 −5.4 −5.9 −3.1 −3.3 −6.2
0.4 0.4 0.3 −0.1 −0.2 0.3 n/a n/a n/a n/a
1.2 1.2 1.5 −10.3 −2.7 −5.7 −5.9 −3.1 −3.3 −6.2
Growth +0.2% +29.6% −768.4%
Per share
0.06 0.06 0.08 33.28 −3.82 −137.92 −177.84 −4,285.66 −348.17 −9.13
0.06 0.06 0.08 n/a −3.82 −137.92 −177.84 −4,285.66 −348.17 −9.13
Growth +0.0% +27.1%
20.0 20.0 20.6 0.3 0.7 0.0 0.0 0.0 0.0 0.7
20.0 20.0 20.6 n/a 0.7 0.0 0.0 0.0 0.0 0.7
Growth +0.0% +2.8% −94.2% −19.8% −97.8% +1,212.4% +7,062.5%

† The diluted share count jumps at 2021 and 2022 and 2024 and 2025 and 2026, so per-share figures either side of that column are not comparable. Usually a split, but the break lands on the restatement boundary rather than on the split date, because every column is that period’s latest filing.

Five years in brief

Worked out from the figures above, not from a press release
  • Revenue shrank 24.9% a year over five years.
  • Operating margin is down 579.9 points on five years ago, at -625.9%.
  • A net loss in 7 of 10 years on file.